PTC Therapeutics, Inc. Depreciation
PTC Therapeutics, Inc. (PTCT) reported Depreciation of $14.20 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-02-19
- PTC Therapeutics, Inc. depreciation for the quarter ending 2020-12-31 was -$24.49M.
- PTC Therapeutics, Inc. depreciation for the quarter ending 2020-09-30 was $11.64M, a 42.98% increase year-over-year.
- PTC Therapeutics, Inc. depreciation for the quarter ending 2020-06-30 was $10.21M, a 32.58% increase year-over-year.
- PTC Therapeutics, Inc. depreciation for the quarter ending 2020-03-31 was $9.23M, a 30.83% increase year-over-year.
- PTC Therapeutics, Inc. depreciation for fiscal 2025 was $14.20M, a 4.70% decline from fiscal 2024.
- PTC Therapeutics, Inc. depreciation for fiscal 2024 was $14.90M, a 7.19% increase from fiscal 2023.
- PTC Therapeutics, Inc. depreciation for fiscal 2023 was $13.90M, a 13.01% increase from fiscal 2022.
- PTC Therapeutics, Inc. depreciation for fiscal 2022 was $12.30M, a 30.85% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 9 month as first filed | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | $14.20M 10-K · filed 2026-02-19 | ||||||
| 2024-12-31 | $14.90M 10-K · filed 2026-02-19 | ||||||
| 2023-12-31 | $13.90M 10-K · filed 2026-02-19 | ||||||
| 2022-12-31 | $12.30M 10-K · filed 2025-02-27 | ||||||
| 2021-12-31 | $9.40M 10-K · filed 2024-02-29 | ||||||
| 2020-12-31 | -$24.49M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | -$12.85M derived: sum of 2 quarters · filed 2023-02-21 | -$2.63M derived: sum of 3 quarters · filed 2023-02-21 | $6.60M 10-K · filed 2023-02-21 | |||
| 2020-09-30 | $11.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $21.85M derived: sum of 2 quarters · filed 2020-10-29 | $31.09M 10-Q · filed 2020-10-29 | $12.88M derived: sum of 4 quarters · filed 2022-02-22 | |||
| 2020-06-30 | $10.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $19.45M 10-Q · filed 2020-08-05 | $1.24M derived: sum of 3 quarters · filed 2022-02-22 | $9.38M derived: sum of 4 quarters · filed 2022-02-22 | |||
| 2020-03-31 | $9.23M 10-Q · filed 2020-04-30 | -$8.97M derived: sum of 2 quarters · filed 2022-02-22 | -$825.00K derived: sum of 3 quarters · filed 2022-02-22 | $6.88M derived: sum of 4 quarters · filed 2022-02-22 | |||
| 2019-12-31 | -$18.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | -$10.06M derived: sum of 2 quarters · filed 2022-02-22 | -$2.36M derived: sum of 3 quarters · filed 2022-02-22 | $4.70M 10-K · filed 2022-02-22 | |||
| 2019-09-30 | $8.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $15.84M derived: sum of 2 quarters · filed 2020-10-29 | $22.90M 10-Q · filed 2020-10-29 | $6.19M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2019-06-30 | $7.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $14.76M 10-Q · filed 2020-08-05 | -$1.96M derived: sum of 3 quarters · filed 2021-02-25 | $5.12M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2019-03-31 | $7.06M 10-Q · filed 2020-04-30 | -$9.66M derived: sum of 2 quarters · filed 2021-02-25 | -$2.58M derived: sum of 3 quarters · filed 2021-02-25 | $3.64M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2018-12-31 | -$16.72M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$9.64M derived: sum of 2 quarters · filed 2021-02-25 | -$3.42M derived: sum of 3 quarters · filed 2021-02-25 | $2.60M 10-K · filed 2021-02-25 | |||
| 2018-09-30 | $7.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $13.29M derived: sum of 2 quarters · filed 2019-10-30 | $19.32M 10-Q · filed 2019-10-30 | $9.87M derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2018-06-30 | $6.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $12.24M 10-Q · filed 2019-08-06 | $2.80M derived: sum of 3 quarters · filed 2020-03-02 | $13.10M derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2018-03-31 | $6.02M 10-Q · filed 2019-05-02 | -$3.42M derived: sum of 2 quarters · filed 2020-03-02 | $6.87M derived: sum of 3 quarters · filed 2020-03-02 | $7.71M derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2017-12-31 | -$9.44M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $852.00K derived: sum of 2 quarters · filed 2020-03-02 | $1.69M derived: sum of 3 quarters · filed 2020-03-02 | $2.30M 10-K · filed 2020-03-02 | |||
| 2017-09-30 | $10.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $11.13M derived: sum of 2 quarters · filed 2018-11-05 | $11.74M 10-Q · filed 2018-11-05 | $12.57M derived: sum of 4 quarters · filed 2019-03-01 | |||
| 2017-06-30 | $836.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $1.45M 10-Q · filed 2018-08-07 | $2.27M derived: sum of 3 quarters · filed 2019-03-01 | $3.08M derived: sum of 4 quarters · filed 2019-03-01 | |||
| 2017-03-31 | $612.00K 10-Q · filed 2018-05-09 | $1.44M derived: sum of 2 quarters · filed 2019-03-01 | $2.25M derived: sum of 3 quarters · filed 2019-03-01 | $3.06M derived: sum of 4 quarters · filed 2019-03-01 | |||
| 2016-12-31 | $823.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $1.64M derived: sum of 2 quarters · filed 2019-03-01 | $2.45M derived: sum of 3 quarters · filed 2019-03-01 | $3.30M 10-K · filed 2019-03-01 | $3.29M 10-K · filed 2017-03-16 | ||
| 2016-09-30 | $813.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $1.63M derived: sum of 2 quarters · filed 2017-11-02 | $2.48M 10-Q · filed 2017-11-02 | $3.30M derived: sum of 4 quarters · filed 2018-03-06 | |||
| 2016-06-30 | $815.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $1.66M 10-Q · filed 2017-08-09 | $2.48M derived: sum of 3 quarters · filed 2018-03-06 | $3.25M derived: sum of 4 quarters · filed 2018-03-06 | |||
| 2016-03-31 | $849.00K 10-Q · filed 2017-05-08 | $1.67M derived: sum of 2 quarters · filed 2018-03-06 | $2.43M derived: sum of 3 quarters · filed 2018-03-06 | $3.12M derived: sum of 4 quarters · filed 2018-03-06 | |||
| 2015-12-31 | $821.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06 | $1.58M derived: sum of 2 quarters · filed 2018-03-06 | $2.27M derived: sum of 3 quarters · filed 2018-03-06 | $2.90M 10-K · filed 2018-03-06 | $2.88M 10-K · filed 2016-02-29 | ||
| 2015-09-30 | $760.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $1.45M derived: sum of 2 quarters · filed 2016-11-03 | $2.08M 10-Q · filed 2016-11-03 | $2.62M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2015-06-30 | $685.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $1.32M 10-Q · filed 2016-08-04 | $1.86M derived: sum of 3 quarters · filed 2017-03-16 | $2.40M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2015-03-31 | $634.00K 10-Q · filed 2016-05-05 | $1.18M derived: sum of 2 quarters · filed 2017-03-16 | $1.72M derived: sum of 3 quarters · filed 2017-03-16 | $2.28M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2014-12-31 | $542.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $1.08M derived: sum of 2 quarters · filed 2017-03-16 | $1.65M derived: sum of 3 quarters · filed 2017-03-16 | $2.23M 10-K · filed 2017-03-16 | |||
| 2014-09-30 | $543.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $1.10M derived: sum of 2 quarters · filed 2015-11-09 | $1.69M 10-Q · filed 2015-11-09 | $2.28M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-06-30 | $562.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-31 | $1.15M 10-Q · filed 2015-07-31 | $1.74M derived: sum of 3 quarters · filed 2016-02-29 | $2.32M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-03-31 | $588.00K 10-Q · filed 2015-05-05 | $1.17M derived: sum of 2 quarters · filed 2016-02-29 | $1.76M derived: sum of 3 quarters · filed 2016-02-29 | $2.36M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2013-12-31 | $585.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $1.17M derived: sum of 2 quarters · filed 2016-02-29 | $1.77M derived: sum of 3 quarters · filed 2016-02-29 | $2.40M 10-K · filed 2016-02-29 | $2.40M 10-K · filed 2014-03-06 | ||
| 2013-09-30 | $589.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $1.19M derived: sum of 2 quarters · filed 2014-11-06 | $1.81M 10-Q · filed 2014-11-06 | $1.81M 10-Q · filed 2013-11-14 | $2.47M derived: sum of 4 quarters · filed 2015-03-02 | ||
| 2013-06-30 | $597.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $1.22M 10-Q · filed 2014-08-07 | $1.22M 10-Q · filed 2013-08-13 | $1.88M derived: sum of 3 quarters · filed 2015-03-02 | $2.54M derived: sum of 4 quarters · filed 2015-03-02 | ||
| 2013-03-31 | $625.00K 10-Q · filed 2014-05-06 | $1.28M derived: sum of 2 quarters · filed 2015-03-02 | $1.95M derived: sum of 3 quarters · filed 2015-03-02 | ||||
| 2012-12-31 | $655.32K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $1.32M derived: sum of 2 quarters · filed 2015-03-02 | $2.70M 10-K · filed 2015-03-02 | $2.70M 10-K · filed 2014-03-06 | |||
| 2012-09-30 | $667.42K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $2.05M 10-Q · filed 2013-11-14 | |||||
| 2012-06-30 | $1.38M 10-Q · filed 2013-08-13 | ||||||
| 2011-12-31 | $2.87M 10-K · filed 2014-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |